Inhibits hCA isoforms (hCAII, hCAIX, hCAXII) with Ki values of 33.6, 24.1, and 6.8 nM, respectively; reduces P-gp activity; inhibits the Wnt/β-catenin signaling pathway; suppresses cancer cell viability, including in the NCI/ADR-RES DOX-resistant cell line.